These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

965 related items for PubMed ID: 33872660

  • 1. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
    Ramaiah MJ, Tangutur AD, Manyam RR.
    Life Sci; 2021 Jul 15; 277():119504. PubMed ID: 33872660
    [Abstract] [Full Text] [Related]

  • 2. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
    Li Y, Seto E.
    Cold Spring Harb Perspect Med; 2016 Oct 03; 6(10):. PubMed ID: 27599530
    [Abstract] [Full Text] [Related]

  • 3. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC, Jacob LA, Aparna S, Lokanatha D, Saldanha SC.
    J Cancer Res Ther; 2014 Oct 03; 10(3):469-78. PubMed ID: 25313724
    [Abstract] [Full Text] [Related]

  • 4. The role of histone deacetylases (HDACs) in human cancer.
    Ropero S, Esteller M.
    Mol Oncol; 2007 Jun 03; 1(1):19-25. PubMed ID: 19383284
    [Abstract] [Full Text] [Related]

  • 5. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
    Hutt DM, Roth DM, Marchal C, Bouchecareilh M.
    Methods Mol Biol; 2017 Jun 03; 1510():77-91. PubMed ID: 27761814
    [Abstract] [Full Text] [Related]

  • 6. Histone acetylation and the cell-cycle in cancer.
    Wang C, Fu M, Mani S, Wadler S, Senderowicz AM, Pestell RG.
    Front Biosci; 2001 Apr 01; 6():D610-29. PubMed ID: 11282573
    [Abstract] [Full Text] [Related]

  • 7. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
    Vahid F, Zand H, Nosrat-Mirshekarlou E, Najafi R, Hekmatdoost A.
    Gene; 2015 May 10; 562(1):8-15. PubMed ID: 25701602
    [Abstract] [Full Text] [Related]

  • 8. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application.
    Santini V, Gozzini A, Ferrari G.
    Curr Drug Metab; 2007 May 10; 8(4):383-93. PubMed ID: 17504226
    [Abstract] [Full Text] [Related]

  • 9. Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.
    Mekala JR, Naushad SM, Ponnusamy L, Arivazhagan G, Sakthiprasad V, Pal-Bhadra M.
    Gene; 2018 Jan 30; 641():248-258. PubMed ID: 29038000
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Histone acetylation in gene regulation.
    Verdone L, Agricola E, Caserta M, Di Mauro E.
    Brief Funct Genomic Proteomic; 2006 Sep 30; 5(3):209-21. PubMed ID: 16877467
    [Abstract] [Full Text] [Related]

  • 12. Histone deacetylase inhibitors: current status and overview of recent clinical trials.
    Ma X, Ezzeldin HH, Diasio RB.
    Drugs; 2009 Oct 01; 69(14):1911-34. PubMed ID: 19747008
    [Abstract] [Full Text] [Related]

  • 13. The emerging roles of HDACs and their therapeutic implications in cancer.
    Hai R, Yang D, Zheng F, Wang W, Han X, Bode AM, Luo X.
    Eur J Pharmacol; 2022 Sep 15; 931():175216. PubMed ID: 35988787
    [Abstract] [Full Text] [Related]

  • 14. Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents.
    Hanikoglu A, Hanikoglu F, Ozben T.
    Curr Protein Pept Sci; 2018 Sep 15; 19(3):333-340. PubMed ID: 28059044
    [Abstract] [Full Text] [Related]

  • 15. Histone acetyl transferases as emerging drug targets.
    Dekker FJ, Haisma HJ.
    Drug Discov Today; 2009 Oct 15; 14(19-20):942-8. PubMed ID: 19577000
    [Abstract] [Full Text] [Related]

  • 16. HDAC modulation and cell death in the clinic.
    Dell'Aversana C, Lepore I, Altucci L.
    Exp Cell Res; 2012 Jul 01; 318(11):1229-44. PubMed ID: 22336671
    [Abstract] [Full Text] [Related]

  • 17. HDACi--going through the mechanisms.
    Wanczyk M, Roszczenko K, Marcinkiewicz K, Bojarczuk K, Kowara M, Winiarska M.
    Front Biosci (Landmark Ed); 2011 Jan 01; 16(1):340-59. PubMed ID: 21196174
    [Abstract] [Full Text] [Related]

  • 18. microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia.
    Roccaro AM, Sacco A, Jia X, Azab AK, Maiso P, Ngo HT, Azab F, Runnels J, Quang P, Ghobrial IM.
    Blood; 2010 Sep 02; 116(9):1506-14. PubMed ID: 20519629
    [Abstract] [Full Text] [Related]

  • 19. HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation.
    Gaub P, Tedeschi A, Puttagunta R, Nguyen T, Schmandke A, Di Giovanni S.
    Cell Death Differ; 2010 Sep 02; 17(9):1392-408. PubMed ID: 20094059
    [Abstract] [Full Text] [Related]

  • 20. Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics.
    Hadnagy A, Beaulieu R, Balicki D.
    Mol Cancer Ther; 2008 Apr 02; 7(4):740-8. PubMed ID: 18413789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.